PLRX

0.59514.02%
MK

Minnie Kuo

Chief Operating Officer

Ms. Minnie Kuo was Chief Development Officer of Pliant Therapeutics, Inc. from September 2023 to December 10, 2025. Ms. Minnie Kuo is Chief Operating Officer of Pliant Therapeutics, Inc. from December 10, 2025. Ms. Kuo is an experienced biotechnology and pharmaceutical executive with multinational clinical development experience across various therapeutic areas including respiratory, oncology, neurodegenerative and inflammatory. Prior to joining Pliant, she held roles of increasing responsibilities at Vir Biotechnology, serving as Senior Vice President of Translational and Clinical Development Operations. In this role, she served as the operational officer to the Chief Medical Officer, overseeing business operations, clinical operations and organizational planning across the entire clinical portfolio. Prior to Vir, she held senior clinical operations roles at Nektar Therapeutics and Gilead Sciences. At Gilead, she oversaw the strategic direction of multiple compounds and indications within the Gilead's inflammation and hepatic portfolios. Earlier in her career, she held global project management and clinical study management roles at the clinical research organization ICON and at Roche/Genentech. Ms. Kuo held global project management and clinical study management roles at clinical research organizations including ICON and PharmaNet. Ms. Kuo received her Bachelor of Arts degree in biochemistry and healthcare from the University of California, San Diego and a Master of Science degree in organizational development from the University of San Francisco.

Positions